Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 44

Results For "pain"

482 News Found

Philips set to acquire Vesper Medical
Medical Device | December 14, 2021

Philips set to acquire Vesper Medical

Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease


Kaka-Ba hospital surgeons perform surgery to correct spine disorder
Hospitals | December 13, 2021

Kaka-Ba hospital surgeons perform surgery to correct spine disorder

Scoliosis is a disorder of the spine, and its surgeries are generally done only in large hospitals in big cities.


Moderna announces positive interim Phase 1 data for mRNA flu vaccine
Biotech | December 13, 2021

Moderna announces positive interim Phase 1 data for mRNA flu vaccine

Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed


IPM registers 6 % yoy revenue growth in Nov 2021.
News | December 08, 2021

IPM registers 6 % yoy revenue growth in Nov 2021.

Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.


Amrutanjan Health Care opens first store in Chennai
News | December 02, 2021

Amrutanjan Health Care opens first store in Chennai

The offline store launch will complement the E-commerce website in building a rich consumer shopping experience


ZyCoV-D to be initially administered in seven states
News | December 02, 2021

ZyCoV-D to be initially administered in seven states

The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20


Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D
News | November 25, 2021

Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D

The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022


Amneal gets approval for Difluprednate ophthalmic emulsion
Drug Approval | November 22, 2021

Amneal gets approval for Difluprednate ophthalmic emulsion

The company is moving towards complex and more differentiated products


European Commission approves Celltrion’s Covid-19 medicine
Drug Approval | November 15, 2021

European Commission approves Celltrion’s Covid-19 medicine

The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week


Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
News | November 12, 2021

Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22

Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.